Influence of plasma amino acid level on vasopressin secretion

Diabetes and Metabolism

Volumn 29, Issue 4 I, 2003, Pages 352-361

  Schmitt, F ^a,b   Bresson, J L ^b   Beressi, N ^b   Bichet, D G ^c   Chauveau, D ^b   Bankir, L ^a,d  

^a INSTITUT DU FER À MOULIN   (France)

^b HÔPITAL NECKER ENFANTS MALADES   (France)

^c HÔPITAL DU SACRÉ COEUR DE MONTRÉAL   (Canada)

^d INSERM   (France)

Author keywords

Diabetes Mellitus; Diuresis; Osmolar Clearance; Plasma Osmolality; Plasma Sodium Concentration

Indexed keywords

AMINO ACID; ISOTONIC SOLUTION; SODIUM; VASOPRESSIN;

ADULT; AMINO ACID BLOOD LEVEL; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CORRELATION ANALYSIS; CROSSOVER PROCEDURE; DIABETES MELLITUS; HORMONAL REGULATION; HUMAN; HUMAN EXPERIMENT; HYPERGLYCEMIA; KIDNEY FUNCTION; MALE; NORMAL HUMAN; OSMOTIC DIURESIS; PLASMA OSMOLALITY; SIGNAL TRANSDUCTION; TIME SERIES ANALYSIS; VASOPRESSIN RELEASE;

EID: 0141844563     PISSN: 12623636     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1262-3636(07)70046-0     Document Type: Article

References (49)

1. Zerbe RL, Vinicor F, Robertson GL. Plasma vasopressin in uncontrolled diabetes mellitus. Diabetes, 1979, 28, 503-8.
2. Walsh CH, Baylis PH, Malins JM. Plasma arginine vasopressin in diabetic ketoacidosis. Diabetologia, 1979, 16, 93-6.
3. Kamoi K, Ishibashi M, Yamaji T. Thirst and plasma levels of vasopressin, angiotensin II and atrial natriuretic peptide in patients with non-insulin-dependent diabetes mellitus. Diabetes Res Clin Pr, 1991, 11, 195-202.
4. Tallroth G, Ryding E, Ekman R, Agardh CD. The response of regulatory peptides to moderate hypoglycaemia of short duration in type 1 (insulin-dependent) diabetes mellitus and in normal man. Diabetes Res, 1992, 20, 73-85.
5. Iwasaki Y, Kondo K, Murase T, Hasegawa H, Oiso Y. Osmoregulation of plasma vasopressin in diabetes mellitus with sustained hyperglycemia. J Neuroendocrinol, 1996, 8, 755-60.
6. Brooks DD, Nutting DF, Crofton JT, Share L. Vasopressin in rats with genetic and streptozotocin-induced diabetes. Diabetes, 1989, 38, 54-7.
7. Granda TG, Velasco A, Rausch A. Variations and interrelation between vasopressin and plasma osmolality in diabetic rats with insulin treatment. Life Sci, 1998, 63, 1305-13.
8. Ahloulay M, Schmitt F, Déchaux M, Bankir L. Vasopressin and urinary concentrating activity in diabetes mellitus. Diabetes Metab, 1999, 25, 213-22.
9. Bardoux P, Martin H, Ahloulay M, et al. Vasopressin contributes to hyperfiltration, albuminuria, and renal hypertrophy in diabetes mellitus: study in vasopressin-deficient Brattleboro rats. Proc Natl Acad Sci USA, 1999, 96, 10397-402.
10. Bankir L, Ahloulay M, Bardoux P. Vasopressin and diabetes mellitus. Nephron, 2001, 87, 8-18.
11. Spira A, Gowrishankar M, Halperin ML. Factors contributing to the degree of polyuria in a patient with poorly controlled diabetes mellitus. Am J Kidney Dis, 1997, 30, 829-35.
12. Bardoux P, Bichet DG, Martin H, et al. Vasopressin increases urinary albumin excretion: involvement of V2 receptors and the renin-angiotensin system. Nephrol Dial Transplant, 2003, 18, 497-506.
13. Bouby N, Bachmann S, Bichet D, Bankir L. Effect of water intake on the progression of chronic renal failure in the 5/6 nephrectomized rat. Am J Physiol, 1990, 258, F973-9.
14. Bouby N, Hassler C, Bankir L. Contribution of vasopressin to progression of chronic renal failure; study in Brattleboro rats. Life Sci, 1999, 65, 991-1004.
15. Bankir L, Bouby N. Vasopressin and urinary concentration: Additional risk factors in the progression of chronic renal failure. Am J Kidney Dis, 1991, 17, 20-6.
16. Bardoux P, Bruneval P, Heudes D, Bouby N, Bankir L. Diabetes-induced albuminuria: role of antidiuretic hormone as revealed by chronic V2 receptor antagonism in rats. Nephrol Dial Transplant, 2003, In press.
17. Thompson CJ, Davis SN, Butler PC, Charlton JA, Baylis PH. Osmoregulation of thirst and vasopressin secretion in insulin-dependent diabetes mellitus. Clinical Sci, 1988, 74, 599-606.
18. Zerbe RL, Vinicor F, Robertson GL. Regulation of plasma vasopressin in insulin-dependent diabetes mellitus. Am J Physiol, 1985, 249, E317-25.
19. Van-Itallie CM, Fernstrom JD. Osmolal effects on vasopressin secretion in the streptozotocin-diabetic rat. Am J Physiol, 1982, 242 E411-7.
20. Zerbe RL, Robertson GL. Osmoregulation of thirst and vasopressin secretion in human subjects: effect of various solutes. Am J Physiol, 1983, 224, E607-14.
21. Bankir L, Trinh-Trang-Tan MM. Urea and the Kidney. In: Brenner B M, eds. "The Kidney (6th Edition)". Philadelphia: W B Saunders Company, 2000, 637-679.
22. Trevisan R, Marescotti C, Avogaro A, Tessari P, Prato SD, Tiengo A. Effects of different insulin administrations on plasma amino acid profile in insulin-dependent diabetic patients. Diabetes Res, 1989, 12, 57-62.
23. Szabo A, Kenesei E, Körner A, Miltényi M, Szücs L, Nagy I. Changes in plasma and urinary amino acid levels during diabetic ketoacidosis in children. Diabetes Res Clin Pract, 1991, 12, 91-7.
24. Luetscher JA. The metabolism of amino acids in diabetes mellitus. J Clin Invest, 1942, 21, 275-9.
25. Hagenfeldt L, Dahlquist G, Persson B. Plasma amino acids in relation to metabolic control in insulin-dependent diabetic children. Acta Pœdiatr Scand, 1989, 78, 278-82.
26. Felig P, Marliss E, Ohoman JL, Cahill GF. Plasma amino acid levels in diabetic ketoacidosis. Diabetes, 1970, 19, 727-9.
27. Berger M, Zimmermann-Telschow H, Berchtold P, et al. Blood amino acid levels in patients with insulin excess (functioning insulinoma) and insulin deficiency (diabetic ketoacidosis). Metabolism, 1978, 27, 793-9.
28. Hernandez T, Coulson RA. The effect of insulin on amino acid metabolism. J Biochem, 1961, 79, 596-605.
29. Pijl H, van-Loon BJP, Toornvliet AC, et al. Insulin-induced decline of plasma amino acid concentrations in obese subjects with and without non-insulin-dependent diabetes. Metabolism, 1994, 43, 640-6.
30. Rosenlund BL. Effects of insulin on free amino acids in plasma and the role of the amino acid metabolism in the etiology of diabetic microangiopathy. Biochem Med Metabolic Biol, 1993, 49, 375-91.
31. Zinneman HH, Nuttall FQ, Goetz FC. Effect of endogenous insulin on human amino acid metabolism. Diabetes, 1966, 15, 5-8.
32. Hadi-Aïssa A, Bankir L, Fraysse M, et al. Influence of the level of hydration on the renal response to a protein meal. Kidney Int, 1992, 42, 1207-16.
33. Chan AYM, Cheng ML, Keil LC, Myers BD. Functional response of healthy and diseased glomeruli to a large, protien-rich protein meal. J Clin Invest, 1988, 81, 245-54.
34. Daniels BS, Hostetter TH. Effect of dietary protein intake on vasoactive hormones. Am J Physiol, 1990, 258, R1095-100.
35. Lifschitz MD. The natriuretic effect of the organic acid paraaminohippurate. J Lab Clin Med, 1976, 88, 895-903.
36. Bennett WM, Roberts D, Porter GA. The natriuretic effect of p-aminohippurate in man. Nephron, 1976, 16, 197-204.
37. Bichet DG, Kortas C, Mettauer B, et al. Modulation of plasma and platelet vasopressin by cardiac function in patients with heart failure. Kidney Int, 1986, 29, 1188-96.
38. Bichet DG, Arthus MF, Barjon JN, Lonergan M, Kortas C. Human "platelet fraction" arginine-vasopressin. Potential physiological role. J Clin Invest, 1987, 79, 881-7.
39. Slocum RH, Cummings JG. Amino acid analysis in physiological samples. In: Hommes FA, eds. "Techniques in diagnostic human genetics, a laboratory manual". New-York: Wiley-Liss, 1991, 87-126.
40. Galli A, Jeanmaire J. Dosage colorimétrique de l'inuline dans le sang et dans les urines. Application à l'analyse automatique. Ann Biol Clin, 1965, 23, 931-41.
41. Castellino P, Coda B, DeFronzo RA. Effect of amino acid infusion on renal hemodynamics in humans. Am J Physiol, 1986, 251, F132-40.
42. Giordano M, castellino P, McConnell EL, DeFronzo RA. Effect of amino acid infusion on renal hemodynamics in humans: a dose-response study. Am J Physiol, 1994, 267, F703-8.
43. Amiel C, Blanchet F, Friedlander G, Nitenberg A. Renal functional reserve. Nephrol Dial Transplant, 1990, 5, 763-70.
44. Claris-Appiani A, Ardissino G, Tirelli AS, et al. Metabolic factors in the renal response to amino acid infusion. Am J Nephrol, 1998, 18, 359-66.
45. Robertson GL. The regulation of vasopressin function in health and disease. Recent Progr Horm Res, 1977, 33, 333-85.
46. Mechaly I, Krosniak M, Azay J, et al. Interactive computerized microscopy as a tool for quantifying vascular remodelling effects of diabetes and Vla receptor antagonist SR 49059 on rat mesenteric arterial bed. J Pharmacol Toxicol Methods, 1999, 41, 59-67.
47. Katz MA. Hyperglycemia-induced hyponatremia. Calculation of expected serum sodium depression. N Engl J Med, 1973, 289, 843-4.
48. Hillier TA, Abbott RD, Barrett EJ. Hyponatremia: evaluating the correction factor for hyperglycemia. Am J Med, 1999, 106, 399-403.
49. Goldberg DJ, Walesky M, Sherwin RS. Effect of somatostatin on the plasma amino acid response to ingested protein in man. Metabolism, 1979, 28, 866-73.